CV Sciences (CVSI) Non-Current Deferred Tax Liability (2013 - 2026)

CV Sciences (CVSI) reported Non-Current Deferred Tax Liability of $7000.0 for Q1 2026, up 75.0% on a YoY basis from $4000.0 in Q1 2025, and little changed sequentially from $7000.0 in Q4 2025.

CV Sciences (CVSI) Non-Current Deferred Tax Liability (2013 - 2026) Analysis & Trends

CV Sciences (CVSI) has 13 years of Non-Current Deferred Tax Liability data on file, last reported at $7000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Deferred Tax Liability rose 75.0% year-over-year to $7000.0; the trailing twelve-month figure through Mar 2026 stood at $7000.0 (up 75.0% YoY), and the FY2025 full-year result was $7000.0, down 83.33% from the prior year.
  • Non-Current Deferred Tax Liability was little changed at $7000.0 in Q1 2026, from $7000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $240000.0 in Q4 2022 to a low of $4000.0 in Q1 2025.
  • A 5-year average of $42705.9 and a median of $19000.0 in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability soared 287.1% in 2022 and plunged 83.33% in 2025, its largest moves.
  • Tracing CVSI's Non-Current Deferred Tax Liability over 5 years: stood at $240000.0 in 2022, then slumped by 40.83% to $142000.0 in 2023, then tumbled by 70.42% to $42000.0 in 2024, then sank by 83.33% to $7000.0 in 2025, then changed by 0.0% to $7000.0 in 2026.
  • Business Quant data shows CVSI's Non-Current Deferred Tax Liability at $7000.0 in Q1 2026, $7000.0 in Q4 2025, and $4000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 CV Sciences 3.74 Mn 3.43 Mn 1.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7,000.00
Mar 31, 2026 7,000.00
Dec 31, 2025 7,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 4,000.00
Sep 30, 2025 4,000.00
Jun 30, 2025 4,000.00
Jun 30, 2025 4,000.00
Mar 31, 2025 4,000.00
Mar 31, 2025 4,000.00
Dec 31, 2024 42,000.00
Dec 31, 2024 42,000.00
Sep 30, 2024 19,000.00
Sep 30, 2024 19,000.00
Jun 30, 2024 19,000.00
Jun 30, 2024 19,000.00
Mar 31, 2024 19,000.00
Mar 31, 2024 19,000.00
Dec 31, 2023 142,000.00
Dec 31, 2023 142,000.00